Casein coated drug-loaded iron oxide nanoparticles
This disclosure relates to nanoparticle drug delivery systems composed of casein (CN) coated nanoparticles, e.g., iron oxide nanoparticles coated with an inner layer and an out layer comprising the milk protein casein. In certain embodiments, drug molecules are incorporated into an inner polymeric layer coating the nanoparticles, which are subsequently coated with a casein containing outer layer, i.e., a layer-by-layer (LBL) construction. Oral administration of these casein coated nanoparticles are contemplated as experiments indicated sufficiently stability in conditions that simulate the conditions of the gut. Drugs that were loaded into the nanoparticle systems were released when the casein outer layer was gradually degraded in the presence of an intestinal protease meant to simulate conditions of the intestine.
1. A pharmaceutical composition comprising
a particle;
an inner coating on the particle comprising an amphiphilic polymer providing an space for embedding a hydrophobic drug within the inner coating, wherein a hydrophobic drug is in the space of the inner coating; and
an outer coating on the inner coating wherein the outer coating is crosslinked casein molecules.
2. The pharmaceutical composition of claim 1 , wherein the particle is an iron oxide nanoparticle.
3. The pharmaceutical composition of claim 1 , wherein the amphiphilic polymer comprises maleic acid and octadecene monomers.
4. The pharmaceutical composition of claim 1 , wherein the hydrophobic drug is an anticancer drug.
5. The pharmaceutical composition of claim 4 , wherein the anticancer drug is doxorubicin.
6. The pharmaceutical composition of claim 4 , wherein the crosslinked casein molecules are made by the process of mixing casein and the particle comprising the inner coating in the presence of glutaraldehyde.